Successful Management of an Intra-Operative Pulmonary Tumor Embolism During Resection of a Retroperitoneal Leiomyosarcoma
Shengmei Zhu,Shaohui Guo,Canbing Li,Lihui Luo,Yong-Xing Yao
DOI: https://doi.org/10.3760/cma.j.issn.0366-6999.20121080
2013-01-01
Abstract:Pulmonary tumor embolisms due to renal cell carcinoma are common.1 In contrast, intra-operative pulmonary artery embolisms due to the release of large tumor fragments during surgery for retroperitoneal leiomyosarcoma have not been reported. When a massive tumor embolus does occur, a patient's survival depends on prompt surgical intervention.2 In this report, a patient experienced a pulmonary tumor embolism during resection of a retroperitoneal leiomyosarcoma, and the condition was successfully treated. However, for the hemodynamic collapse that occurred, a pulmonary arteriography was followed by an emergency pulmonary embolectomy with cardiopulmonary bypass. A 37-year-old male with a body weight of 70 kg and previously in good health, was diagnosed with a retroperitoneal lesion during a medical examination. A computed tomography (CT) scan and magnetic resonance imaging (MRI) confirmed the presence of a large enhanced mass near the right kidney, approximately 7.4 cm× 7.6 cm in size. Ultrasonic imaging revealed a 3.3 cm× 1.4 cm parenchymal echo in the inferior vena cava (IVC) nearby the mass, although implantation metastasis to the liver, lung, or brain were not detected, nor was extension into the right atrium (Figure 1). A preoperative examination including hematological and serum biochemical studies, an electrocardiogram (ECG), a chest X-ray, and pulmonary function tests, detected no obvious abnormalities.Figure 1.: Preoperative imaging scans show a large enhanced mass present near the right kidney (arrows). The inferior vena cava was also compressed and a defect in filling was detected. A: CT transverse section. B: CT with coronal reconstruction view. C: Sonography. D: MRI presenting an obstruction of the middle inferior vena cava.For treatment, the patient underwent a radical resection under general anesthesia. Both the radial artery and the internal jugular vein were cannulated in order to provide continuous monitoring of arterial blood pressure and central venous pressure, respectively. Additional monitoring included pulse oxymetry, tidal volume, airway pressure, body temperature, inspiratory and expiratory gas mixtures, and urinary output. Anesthesia was induced with 3 mg midazolam, 10 mg etomidate, and 50 μg sufentanil. Vecuronium (8 mg) was also administered for muscle relaxation. The trachea was intubated and end-tidal carbon dioxide was monitored. Anesthesia was maintained with continuous administration of propofol (4-7 mg·kg-1·h-1) and remifentanyl (15 μg·kg-1·h-1). Intermittently inhaled sevoflurane was targeted to achieve an end-tidal concentration range of 0.7 to 1.1 minimum alveolar concentration (MAC). Procedures involving the radical resection of the extended tumor and a nephrectomy were performed without incident. The estimated blood loss was 600 ml, with 100 ml of urine output and 2500 ml fluid infusion. However, several minutes after the tumor was removed, severe hypotension abruptly manifested with a decrease in blood pressure from 140/65 to 75/55 mmHg. This drop in blood pressure was also accompanied by tachycardia involving an increase from 90 beats/min to 130-149 beats/min. Meanwhile, central venous pressure increased from 12 to 27 mmHg, and end-tidal carbon dioxide tension (PetCO2) decreased from 30 to 20 mmHg. Immediately, 200 μg adrenaline was administered intravenously. Arterial blood analysis subsequently detected the following levels: 133 mmol/L sodium, 5.0 mmol/L potassium, 1.1 mg/dl calcium, hematocrit 26%, pH 7.13, PaCO2 67 mmHg, PaO2 172 mmHg, glucose 168 mg/dl, HCO2 26 mmol/L, and base excess -6.8. A massive pulmonary tumor embolus was suspected. Extremely large doses of epinephrine (20-95 μg·kg-1·min-1) were continuously infused, while intermittent bolus injections were administered as needed to address an extremely unstable hemodynamic condition. The PetCO2 varied from 10 to 17 mmHg. Twenty minutes later, an electrocardiography (ECG) detected electro-mechanical dissociation, and chest compressions were initiated to achieve a perfusion pressure of 60-90/45-70 mmHg. Half an hour later, with a transesophageal echocardiogram (TEE) unavailable, an emergency pulmonary arteriography was performed. An acute embolism was detected in the pulmonary artery. The decision was then made to remove the pulmonary emboli using cardiopulmonary bypass. The cardiovascular surgeon and perfusion team were notified, and an immediate median sternotomy was initiated. A tumor emboli measuring 5 cm× 3 cm× 2 cm was subsequently evacuated from the entrance of the pulmonary artery mainstem. Resuscitation was uneventful following reperfusion and continuous infusion of epinephrine (0.06 μg·kg-1·min-1). A few minutes later, end-tidal carbon dioxide and central venous pressure were 32 mmHg and 10 mmHg, respectively. In addition, PaCO2 was 58 mm Hg. Approximately 25 minutes after the patient was weaned from the cardiopulmonary bypass, a stable hemodynamic condition was achieved. The patient was then transferred to the intensive care unit with intubation maintained. During the postoperative period, the patient developed renal failure. The patient underwent continuous renal replacement therapy for two weeks, after which he received daily hemodialysis due to the persistence of renal failure. Thirty days later, the patient left the intensive care unit and was continuing to receive hemodialysis therapy. In addition, despite the long resuscitation time experienced by the patient, the overall outcome was fairly good, with an absence of any detectable neurological deficit. The final pathological diagnosis was leiomyosarcoma. Microscopically, the tumor was characterized by areas of high cellularity with medium-sized cells containing distinct, cigar-shaped nuclei. Immunohistochemical assays also detected expression of the smooth muscle marker, desmin, while only 10% of tumor cells were positive for CD-117. Tumor cells were also negative for S-100, CD-34, and MyoD1.